Cakupan Terapi Antiretroviral dan Hasil Pemeriksaan Viral Load Pada Pasien Human Immunodeficiency Virus di RSUD RAA Soewondo Pati
Kata Kunci:
pasien HIV, terapi Antiretroviral, viral loadAbstrak
Latar belakang: Pelayanan HIV di RSUD RAA Soewondo Pati meliputi Voluntary Counselling and Testing (VCT) dan Care Support and Testing (CST), dengan pemberian terapi Anti-Retroviral (ARV) sebagai kunci utama dalam pengendalian virus HIV. Di tingkat nasional, capaian target pelayanan HIV menunjukkan angka yang masih rendah, dengan hanya 41% pasien yang menjalani terapi ARV dan 19% yang mengalami supresi virus. Kepatuhan minum obat ARV menjadi faktor penting dalam keberhasilan terapi ini. Tujuan: Untuk mengetahui cakupan terapi ARV dan hasil viral load tersupresi pada pasien HIV di RSUD RAA Soewondo Pati. Metode: Penelitian ini menggunakan desain deskriptif dengan pendekatan data sekunder dari rekam medis pasien HIV yang menjalani terapi ARV di RSUD RAA Soewondo Pati. Data dikumpulkan melalui observasi, wawancara, dan analisis rekam medis untuk mengukur cakupan terapi ARV dan hasil viral load pada pasien HIV. Hasil: Cakupan terapi ARV di RSUD RAA Soewondo Pati tercatat sebesar 77,3%, yang masih di bawah target nasional sebesar 95%. Sementara itu, hasil viral load tersupresi mencapai 78,6%, juga masih kurang dari target 95%. Kesimpulan: Cakupan terapi ARV dan hasil viral load tersupresi pada pasien HIV di RSUD RAA Soewondo Pati belum mencapai target nasional yang ditetapkan. Keberhasilan terapi ARV sangat bergantung pada kepatuhan pasien dalam menjalani pengobatan secara teratur, yang perlu ditingkatkan untuk mencapai hasil yang optimal dalam pengendalian virus HIV.
Kata kunci: pasien HIV, terapi antiretroviral, viral load
__________________________________________________________________________
Abstract
Background: HIV services at RSUD RAA Soewondo Pati include Voluntary Counseling and Testing (VCT) and Care Support and Testing (CST), with the provision of Anti-Retroviral (ARV) therapy as the main key to controlling HIV. At the national level, the achievement of HIV service targets is still low, with only 41% of patients undergoing ARV therapy and 19% experiencing viral suppression. Compliance with taking ARV medication is an important factor in the success of this therapy. Objective: To determine the coverage of ARV therapy and the results of suppressed viral load in HIV patients at RSUD RAA Soewondo Pati. Method: This study used a descriptive design with a secondary data approach from medical records of HIV patients undergoing ARV therapy at RSUD RAA Soewondo Pati. Data were collected through observation, interviews, and medical record analysis to measure the coverage of ARV therapy and viral load results in HIV patients. Result: The coverage of ARV therapy at RSUD RAA Soewondo Pati was recorded at 77.3%, which is still below the national target of 95%. Meanwhile, the results of suppressed viral load reached 78.6%, also still below the target of 95%. Conclusion: The coverage of ARV therapy and the results of suppressed viral load in HIV patients at RSUD RAA Soewondo Pati have not reached the national target set. The success of ARV therapy is highly dependent on patient compliance in undergoing regular treatment, which needs to be improved to achieve optimal results in controlling HIV.
Keywords: HIV patients, antiretroviral therapy, viral load
Referensi
WHO. HIV statistic, globally and by WHO region. 2023. Global HIV Programme. Available from: http://www.who.int
Kemenkes R. Laporan Tahunan HIV AIDS Tahun 2022. 2022.
Tomescu S, Crompton T, Adebayo J, Akpan F, Dauda DS, Allen Z, et al. Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021. BMJ Open. 2023;13(5):e065950.
Permana DAS, Faizal IA, Ningrum DM. Profil Terapi Antiretoviral (ARV) Beserta Nilai Parameter Viral Load (Vl) Pada Pasien Hiv/Aids Di Puskesmas “X” Distrik Cilacap. Pharmaqueous J Ilm Kefarmasian. 2021;3(2):36–44.
Chauvin M, Sauce D. Mechanisms of immune aging in HIV. Clin Sci. 2022;136(1):61– 80.
Setiarto RHB, Karo MB, Keb ST, SKM MK, Tambaip T. Penanganan Virus HIV/AIDS. Deepublish; 2021.
Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11(1).
Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel. Jama. 2020;324(16):1651-69
Paparizos V, Kourkounti S. HIV Infection and AIDS: The Present Status of Antiretroviral Therapy. In: European Handbook of Dermatological Treatments. Springer; 2023. p. 429–42.
Kone B, Goita D, Dolo O, Traore D, Sogoba D, Somboro A, et al. Performance comparison of Xpert HIV-1 viral load assay and Roche Taqman and Abbott M2000 RT in Bamako, Mali. J AIDS Clin Res. 2020;11(7).
Wisaksana R, Hartantri Y, Hutajulu E. Risk Factors Associated with Unsuppressed Viral Load in People Living with HIV Receiving Antiretroviral Treatment in Jawa Barat, Indonesia. HIV/AIDS-Research Palliat Care. 2024;1–7.
Suryanto Y, Sofiyani Y, Agung RN. Hubungan self-determination dengan kepatuhan minum obat antiretroviral pada pasien HIV di Rumah Sakit Umum Daerah Karawang. J Ilmu Kesehat Bhakti Husada Heal Sci J. 2024;15(01):230–40.
Hidayati AN. Manajemen HIV/AIDS: terkini, komprehensif, dan multidisiplin. Airlangga University Press; 2020.
Hamzah M, Esfandiari F, Angraini M, Kusmana A. Hubungan Kepatuhan Minum Obat Antiretroviral Pasca 6-12 Bulan dengan Kadar Viral Load Pada Lelaki Seks Lelaki (LSL) yang Terinfeksi Human Immunodeficiency Virus (HIV) Di Bandar Lampung Tahun 2019. J Med Malahayati. 2020;4(3):226–35.
Mahariski PA, Puspawati NMD, Indira IGAAE, Praharsini IGAA, Permana A. Pre- exposure prophylaxis (PrEP) pada pencegahan human immunodeficiency virus (HIV) dan dampaknya terhadap infeksi menular seksual. Intisari Sains Medis. 2023;14(2):730– 8.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2025 JURNAL INOVASI DAN PENGABDIAN MASYARAKAT INDONESIA

Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.